000 01421 a2200433 4500
005 20250517205323.0
264 0 _c20181024
008 201810s 0 0 eng d
022 _a2040-2392
024 7 _a10.1186/s13229-018-0203-y
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKarhson, Debra S
245 0 0 _aPlasma anandamide concentrations are lower in children with autism spectrum disorder.
_h[electronic resource]
260 _bMolecular autism
_c2018
300 _a18 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650 0 4 _aArachidonic Acids
_xblood
650 0 4 _aAutistic Disorder
_xblood
650 0 4 _aBiomarkers
_xblood
650 0 4 _aCannabinoid Receptor Agonists
_xblood
650 0 4 _aCase-Control Studies
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aEndocannabinoids
_xblood
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aPolyunsaturated Alkamides
_xblood
700 1 _aKrasinska, Karolina M
700 1 _aDallaire, Jamie Ahloy
700 1 _aLibove, Robin A
700 1 _aPhillips, Jennifer M
700 1 _aChien, Allis S
700 1 _aGarner, Joseph P
700 1 _aHardan, Antonio Y
700 1 _aParker, Karen J
773 0 _tMolecular autism
_gvol. 9
_gp. 18
856 4 0 _uhttps://doi.org/10.1186/s13229-018-0203-y
_zAvailable from publisher's website
999 _c28203274
_d28203274